Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-MC-01 for interstitial cystitis (phase 1/2a, single-center, Korea)
KCT0006999Phase 2Recruiting
- Sponsor
- Mirae Cell Bio
- Start
- Feb 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of MR-MC-01 in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Mirae Cell Bio. Started Feb 2022; status: recruiting.
02
Drugs
MR-MC-01
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on KCT0006999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006999.